C1q tumour necrosis factor related protein 1

Drug Profile

C1q tumour necrosis factor related protein 1

Alternative Names: C1q TNF Related Protein 1; C1QTNF1; CTRP 1; zsig37

Latest Information Update: 14 Sep 2010

Price : $50

At a glance

  • Originator ZymoGenetics
  • Developer Seattle Life Sciences
  • Class Antithrombotics; Proteins
  • Mechanism of Action Platelet activating factor inhibitors; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • Discontinued Thrombosis

Most Recent Events

  • 14 Sep 2010 Discontinued - Preclinical for Thrombosis in USA (unspecified route)
  • 30 May 2009 Programme licensed to Seattle Life Sciences
  • 05 Dec 2006 Preclinical data added to the Thromboses pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top